▲ | echelon 6 days ago | |||||||
That and IRS section 174. | ||||||||
▲ | jfactorial 5 days ago | parent | next [-] | |||||||
TL;DR: recent changes in Section 174 IRC will _incentivize_ R&D spending, not cause layoffs of researchers and developers. Section 174 allows businesses to deduct their domestic R&D expenses. In 2017 Trump made businesses have to amortize these expenses over 5 years instead of deducting them, starting in 2022 (it is common for an administration to write laws that will only have a negative effect after they're gone). This move wrecked the R&D tax credit. Many US businesses stopped claiming R&D tax credits entirely as a result. Others had surprise tax bills. Trump's second term work is now to undo the disaster he caused (S.O.P.). Congress has reversed the amortization rule and businesses can again deduct R&D expenses immediately. This is a good thing rolling back a bad thing. The bad thing might have been responsible for layoffs a few years ago, but it will have only positive impact on 2025. | ||||||||
| ||||||||
▲ | Apocryphon 6 days ago | parent | prev [-] | |||||||
And now, economic uncertainty due to tariffs | ||||||||
|